Form D · Other Technology

Neosoma, Inc.

Groton, MA · CIK 0001833002

Offering snapshot reported Mar 27, 2026 · SEC filing

Reported sold
$3.52M
Offering amount: $5.8M
Investors reported
52
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 18, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 27, 2026Initial$3,517,368No comparison52SEC filing
Jan 8, 2025Initial$345,000No comparison5SEC filing
Jul 26, 2024Initial$5,053,211No comparison54SEC filing
Feb 13, 2024Amendment$1,185,000$810,000vs Aug 31, 202315SEC filing
Aug 31, 2023Initial$375,000No comparison4SEC filing
Nov 20, 2020Initial$75,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-578134

Source: Form D, filed Mar 27, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aly Abayazeed Director, Executive
Michael Hill Executive
Oleg Ikhelson Director
Will Iselin Director
Kenneth Kolodziej Director, Executive
John Liedtky Executive
Deborah Millin Director
Kevin Richard Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
44 Farmers Row
Groton, MA, 01450